These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 21078165)
21. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. O'Reilly MA; Hynynen K Radiology; 2012 Apr; 263(1):96-106. PubMed ID: 22332065 [TBL] [Abstract][Full Text] [Related]
22. Blood-Brain Barrier Closure Time After Controlled Ultrasound-Induced Opening Is Independent of Opening Volume. O'Reilly MA; Hough O; Hynynen K J Ultrasound Med; 2017 Mar; 36(3):475-483. PubMed ID: 28108988 [TBL] [Abstract][Full Text] [Related]
23. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Yang FY; Fu WM; Yang RS; Liou HC; Kang KH; Lin WL Ultrasound Med Biol; 2007 Sep; 33(9):1421-7. PubMed ID: 17561334 [TBL] [Abstract][Full Text] [Related]
24. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery. Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957 [TBL] [Abstract][Full Text] [Related]
25. Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model. McDannold N; Zhang Y; Supko JG; Power C; Sun T; Peng C; Vykhodtseva N; Golby AJ; Reardon DA Theranostics; 2019; 9(21):6284-6299. PubMed ID: 31534551 [TBL] [Abstract][Full Text] [Related]
26. Focused ultrasound-induced blood-brain barrier disruption enhances the delivery of cytarabine to the rat brain. Zeng HQ; Lü L; Wang F; Luo Y; Lou SF J Chemother; 2012 Dec; 24(6):358-63. PubMed ID: 23174101 [TBL] [Abstract][Full Text] [Related]
27. Monitoring of acoustic cavitation in microbubble-presented focused ultrasound exposure using gradient-echo MRI. Wu CH; Liu HL; Ho CT; Hsu PH; Fan CH; Yeh CK; Kang ST; Chen WS; Wang FN; Peng HH J Magn Reson Imaging; 2020 Jan; 51(1):311-318. PubMed ID: 31125166 [TBL] [Abstract][Full Text] [Related]
28. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. McDannold N; Vykhodtseva N; Hynynen K Ultrasound Med Biol; 2008 Jun; 34(6):930-7. PubMed ID: 18294757 [TBL] [Abstract][Full Text] [Related]
29. The mechanism of interaction between focused ultrasound and microbubbles in blood-brain barrier opening in mice. Tung YS; Vlachos F; Feshitan JA; Borden MA; Konofagou EE J Acoust Soc Am; 2011 Nov; 130(5):3059-67. PubMed ID: 22087933 [TBL] [Abstract][Full Text] [Related]
30. Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model. Arsiwala TA; Sprowls SA; Blethen KE; Fladeland RA; Wolford CP; Kielkowski BN; Glass MJ; Wang P; Wilson O; Carpenter JS; Ranjan M; Finomore V; Rezai A; Lockman PR Fluids Barriers CNS; 2022 Sep; 19(1):72. PubMed ID: 36076213 [TBL] [Abstract][Full Text] [Related]
31. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors. Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759 [TBL] [Abstract][Full Text] [Related]
32. MRI and histological evaluation of pulsed focused ultrasound and microbubbles treatment effects in the brain. Kovacs ZI; Tu TW; Sundby M; Qureshi F; Lewis BK; Jikaria N; Burks SR; Frank JA Theranostics; 2018; 8(17):4837-4855. PubMed ID: 30279741 [TBL] [Abstract][Full Text] [Related]
33. An advanced focused ultrasound protocol improves the blood-brain barrier permeability and doxorubicin delivery into the rat brain. Jung B; Huh H; Lee EH; Han M; Park J J Control Release; 2019 Dec; 315():55-64. PubMed ID: 31669208 [TBL] [Abstract][Full Text] [Related]
34. Microbubble type and distribution dependence of focused ultrasound-induced blood-brain barrier opening. Wang S; Samiotaki G; Olumolade O; Feshitan JA; Konofagou EE Ultrasound Med Biol; 2014 Jan; 40(1):130-7. PubMed ID: 24239362 [TBL] [Abstract][Full Text] [Related]
35. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments. Poon C; Pellow C; Hynynen K Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773 [No Abstract] [Full Text] [Related]
36. Detection of intracerebral hemorrhage and transient blood-supply shortage in focused-ultrasound-induced blood-brain barrier disruption by ultrasound imaging. Fan CH; Liu HL; Huang CY; Ma YJ; Yen TC; Yeh CK Ultrasound Med Biol; 2012 Aug; 38(8):1372-82. PubMed ID: 22579546 [TBL] [Abstract][Full Text] [Related]
37. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles. Deng J; Huang Q; Wang F; Liu Y; Wang Z; Wang Z; Zhang Q; Lei B; Cheng Y J Mol Neurosci; 2012 Mar; 46(3):677-87. PubMed ID: 21861133 [TBL] [Abstract][Full Text] [Related]
38. Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening. Sun T; Samiotaki G; Wang S; Acosta C; Chen CC; Konofagou EE Phys Med Biol; 2015 Dec; 60(23):9079-94. PubMed ID: 26562661 [TBL] [Abstract][Full Text] [Related]
39. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. McDannold N; Vykhodtseva N; Raymond S; Jolesz FA; Hynynen K Ultrasound Med Biol; 2005 Nov; 31(11):1527-37. PubMed ID: 16286030 [TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging enhanced by superparamagnetic iron oxide particles: usefulness for distinguishing between focused ultrasound-induced blood-brain barrier disruption and brain hemorrhage. Liu HL; Hsu PH; Chu PC; Wai YY; Chen JC; Shen CR; Yen TC; Wang JJ J Magn Reson Imaging; 2009 Jan; 29(1):31-8. PubMed ID: 19097103 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]